Head-to-head · WeighScore
Bayan Health vs bmiMD
The verdict
bmiMD takes it — 79.2/100 to 74.6/100.
bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Genuinely flat by dose on both molecules and among the cheapest here — but the page opens on a commitment tab, so the first figure a reader sees is not the monthly one.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bayan Health | bmiMD |
|---|---|---|
| WeighScore | 74.6/100 | 79.2/100 |
| Grade | C | C+ |
| Scorecard rank | #66 | #30 |
| Semaglutide | $129/mo (billed monthly against a protocol that ships three months at a time) | $129/mo month-to-month ($99 only on a 12-month plan) |
| Tirzepatide | $149/mo (billed monthly against a protocol that ships three months at a time) | $179/mo month-to-month ($139 only on a 12-month plan) |
| Coverage | All 50 states (claimed; no list published) | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #66 · C
Strengths
- Both product pages state the price holds at every dose, so the figure does not climb as titration does
- Sells oral drops and microdose tiers below the standard injectable rate, and prices oral orforglipron tablets openly at $269 a month
- Names its clinical network, MD Integrations, and its founding physician
- Publishes an itemized fee table for consultations, follow-ups and quarterly clinical reviews rather than leaving them unpriced
- Ships free, and the medication cost is stated as included in the monthly figure
Where it loses points
- The monthly bill is not a monthly commitment: the Terms require opting out at least fifteen days before the next protocol cycle, and the payment obligation covers the whole two- to three-month protocol shipped
- The refund policy opens “ALL SALES ARE FINAL” and consultations are non-refundable
- The homepage says medication pricing depends on a personalized treatment plan while the product pages say the price is flat at every dose
- The FAQ says service is available nationwide, the Terms say it may not be available in all states, and no list is published
- No pharmacy is named — the site states only that it uses licensed 503A and 503B pharmacies
- No legal entity, entity suffix or street address is published anywhere on the site
- The transparent-pricing table still contains an unedited placeholder row reading “Service name $20”
Graded #30 · C+
Strengths
- Flat at every dose: 2.5 mg and 15 mg cost the same, so titrating up never raises the bill
- Both compounded semaglutide and tirzepatide on one account, plus a sublingual line
- Every rung of both ladders is published with the total charge beside each per-month figure
- All 50 states
Where it loses points
- The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
- The cheapest figures, $99 and $139, require $1,188 or $1,668 paid up front for a full year
- A struck-through $228.60 and $349.20 sit above the ladders under a standing LIMITED TIME label, with no published basis
- Neither the compounding pharmacy nor the prescribing group is named on the product pages
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.